ima Cannabis, a B.C.-based recreational cannabis retail brand with one store in Abbotsford, B.C., and four more opening soon in the province, has acquired Ontario-based retailer, High Tea Cannabis Co. (High Tea). With AGCO approval of the deal through parent company T-CANN Retail Ltd., Jima is now a multi-location, national cannabis brand with a rapid expansion plan and a franchise and affiliate model.

As part of the agreement, Jima will add the Ontario High Tea stores located in Brampton, Scarborough, St. Thomas, York West, and Windsor into its network.

As part of the growth strategy, additional High Tea stores are set to open in the fall of 2021 in York, North York, Hamilton, Beamsville, and Petersburg.

Aurora Cannabis released its fiscal 2021 results on Monday with a decline in revenues to $245 million, from $269 million the prior year. Operating expenses decreased to $283 million, from $466 million in 2020, which resulted in an improvement in the company’s net loss to $695 million, from $3.3 billion the prior year. Aurora Cannabis produces, distributes and sells cannabis and cannabis-related products around the world with brands such as Aurora, San Rafael ’71 and CanniMed, to list a few.

Cenovus Energy Inc. (CVE.TO) +1.8%

Canadian cannabis producer The Valens Company Inc. VLNS, +3.62% VLNCF, +3.01% said Tuesday its effort to list its shares on the Nasdaq "has progressed at a slower pace than originally anticipated." The company expects to begin trading on Nasdaq by the end of fiscal 2021. The stock will continue to trade on Toronto Stock Exchange. Once its moves to the Nasdaq, its stock will no longer be quoted on the OTCQX. Valens hired Stikeman Elliott LLP in Canada and Foley Hoag LLP to advise the company on its Nasdaq listing application process. Valens shares are up 36% so far this year, compared to a dip of 2.4% by the Cannabis ETF THCX, +2.62%.

Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a new-age pharma/nutraceutical company that specializes in the global sexual health, wellness and psychedelics markets by licensing and distributing psychedelic and cannabis-infused products.  The company ushered in a new era of health and wellness as it began trading on the Canadian Securities Exchange last week under the new name and ticker symbol. 

As Love Pharma sets out to bring psychedelic therapies, pharmaceutical alternatives, and sexual enrichment products to market, it will immediately propel its current CBD-infused brands, “Bloom” and “Auralief,” into the marketplace while it continues to develop a host of additional patent-protected products in the company’s pipeline. 

Aurora Cannabis (NASDAQ:ACB) is one of the top marijuana stocks in Canada. It has fallen behind both Tilray (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) in terms of revenue, but it's still a relatively big player in the pot market up north. However, with the company reporting yet another lackluster period this week with respect to revenue growth, it could fall further behind, especially as marijuana producer Hexo (NASDAQ:HEXO) has been trying to grow via acquisitions.

Investors should also pay attention to another company that could soon be on Aurora's heels as well: Village Farm International (NASDAQ:VFF).

There's nothing that can light a fire under marijuana stocks quite like hype around legalization or any kind of reform in the sector. When the Democrats won the run-off Senate elections in Georgia in early January, giving them control of both the House and Senate, shares of the Horizons Marijuana Life Sciences ETF jumped 8% the following day (the S&P 500 was up around 0.6%).

At the time, there was excitement only for the possibility that reform might happen as a result of the Senate results. If there are actual changes, the bullishness could reach a whole other level. And while marijuana legalization may not happen anytime soon, the passage of the Secure and Fair Enforcement (SAFE) Banking Act could be on the horizon.

The first year of the COVID-19 pandemic saw a big increase in alcohol and cannabis sales in Manitoba — but casino revenues plummeted. 

In the 2020-21 fiscal year, liquor sales increased 11 per cent from the year before, to $886 million — a jump Manitoba Liquor & Lotteries attributes in part to stay-at-home orders that kept Manitobans close to their fridges, the Crown corporation's latest annual report says.

As well, cannabis revenues jumped by 56 per cent to $80.2 million in 2020-21, a significant jump from $51.5 million in 2019-20.

Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced the successful receipt of their cannabis sales license from Health Canada following a rigorous application and inspection process. This is in addition to the micro-processing license received November 15, 2019 which has allowed RDT to offer white-label products to multiple Canadian producers.